Radiotherapy in stage I seminoma of the testis

Journal of Clinical Oncology

Volumn 22, Issue 4, 2004, Pages 585-588

  Horwich, Alan ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN;

ABDOMINAL CANCER; ABDOMINAL RADIOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER RISK; CANCER STAGING; CARCINOGENESIS; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; EDITORIAL; HUMAN; LUNG CANCER; METASTASIS; ORCHIECTOMY; PATIENT CARE; PRIORITY JOURNAL; RADIATION DOSE; RISK FACTOR; SAFETY; SEMINOMA; WHOLE BODY RADIATION; ADJUVANT THERAPY; MALE; MORTALITY; NOTE; RADIATION INJURY; RISK; TESTIS TUMOR;

HUMANS; MALE; ORCHIECTOMY; RADIATION INJURIES; RADIOTHERAPY, ADJUVANT; RISK; SEMINOMA; TESTICULAR NEOPLASMS;

EID: 1442283223     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.12.966     Document Type: Editorial

References (30)

1. Zagars G, Ballo M, Lee AK, et al: Mortality after cure of testicular seminoma. J Clin Oncol 22:640-647, 2004
2. Fossȧ SD, Aass N, Kaalhus O: Radiotherapy for testicular seminoma stage I: Treatment results and long-term post-irradiation morbidity in 365 patients. Int J Radiat Oncol Biol Phys 16:383-388, 1989
3. Norwich A, Bell J: Mortality and cancer incidence following radiotherapy for seminoma of the testis. Radiother Oncol 30:193-198, 1994
4. Santoni R, Barbera F, Bertoni F: Stage I seminoma of the testis: A bi-irtstitutional retrospective analysis of patients treated with radiation therapy only. BJU Int 92:47-52, 2003
5. Fossȧ SD, Norwich A, Russell J, et al: Optimal planning target volume for stage I testicular seminoma: A Medical Research Council randomised trial. J Clin Oncol 17:1146-1154, 1999
6. Jones W, Fossȧ S, Meas G, et al: A Randomised Trial of Two Radiotherapy Schedules in the Adjuvant of Stage I Seminoma (MRC TE18): Preliminary Report. Germ Cell Tumours V. Springer, London, UK, 2002, pp 235-236
7. Zagars G, Pollack A: Radiotherapy for stage II testicular seminoma. Int J Radiat Oncol Biol Phys 51:643-649, 2001
8. Mencel PJ, Motzer RJ, Mazumdar M, et al: Advanced seminoma: Treatment results, survival, and prognostic factors in 142 patients. J Clin Oncol 12:120-126, 1994
9. Warde P, Gospodarowicz M, Panzarella T, et al: Management of stage II seminoma. J Clin Oncol 16:290-294, 1998
10. Fossȧ SD, Droz JP, Stoter G, et al: Cisplatin, vincristine and ifosphamide combination chemotherapy of metastatic seminoma: Results of EORTC trial 30874. EORTC GU Group. Br J Cancer 71:619-624, 1995
11. Travis L, Curtis R. Storm H, et al: Risk of Second Malignant Neoplasms Among Long-Term Survivors of Testicular Cancer. J Natl Cancer Inst 89:1429-1439, 1997
12. van Leeuwen FE, Stiggelbout AM, van den Belt-Dusebout AW, et al: Second cancer risk following testicular cancer: A follow-up study of 1,909 patients. J Clin Oncol 11:415-424, 1993
13. Fossȧ SD, Langmark F, Aass N, et al: Second non-germ cell malignancies after radiotherapy of testicular cancer with or without chemotherapy. Br J Cancer 61:639-643, 1990
14. Meinardi M, Gietema J, van der Graaf W, et al: Cardiovascular morbidity in long-term survivors of metastatic testicular cancer. J Clin Oncol 18:1725-1732, 2000
15. Huddart R, Norman A, Shahidi M, et al: Cardiovascular disease as a long-term complication of treatment for testicular cancer. J Clin Oncol 21:1513-1523, 2003
16. Doll DC, Ringenberg QS, Yarbro JW: Vascular toxicity associated with antineoplastic agents. J Clin Oncol 4:1405-1417, 1986
17. Reinders J, Heijmen B, Manouk J, et al: Ischemic heart disease after mantlefield irradiation for Hodgkin's disease in long-term follow-up. Radiother Oncol 51:35-42, 1999
18. Corn BW, Track BJ, Goodman RI: Irradiation-related ischemic heart disease. J Clin Oncol 8:741-750, 1990
19. Cuzick J. Stewart H, Rutqvist L, et al: Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 12:447-453, 1994
20. Lederman GS, Sheldon TA, Chaffey JT: Cardiac disease after mediastinal irradiation for seminoma. Cancer 60:772-776, 1987
21. Hanks GE, Peters T, Owen J: Seminoma of the testis: Long-term beneficial and deleterious results of radiation. Int J Radiat Oncol Biol Phys 24:913-919, 1992
22. Hancock S, Donaldson S, Hoppe R: Cardiac disease following treatment of Hodgkin's disease in children and adolescents. J Clin Oncol 11:1208-1215, 1993
23. Lederman GS, Herman TS, Jochelson M, et al: Radiation therapy of seminoma: 17-year experience at the Joint Center for Radiation Therapy. Radiother Oncol 14:203-208, 1989
24. Fleshner N, Warde P: Controversies in the management of testicular seminoma. Semin Urol Oncol 20:227-233, 2002
25. Fossȧ SD, Jones WG, Stenning SP, et al: Quality of life (QL) after radiotherapy (RT) for stage I seminoma: Results from a randomised trial of two RT schedules (MRC TE18). Proc Am Soc Clin Oncol 21:188a, 2002 (abstr 750)
26. Warde P, Specht L, Horwich A, et al: Prognostic factors for relapse in stage I seminoma managed by surveillance: A pooled analysis. J Clin Oncol 20:4448-4452, 2002
27. Chan J. Kabeto M, Oldread A: The use of preferences to measure the benefit of adjuvant radiation therapy for stage I seminoma. Int J Radiat Oncol Biol Phys 53:934-941, 2002
28. Cullen MH, Stenning SP. Parkinson MC, et al: Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: A Medical Research Council report. J Clin Oncol 14:1106-1113, 1996
29. Dieckmann KP, Bruggeboes B, Pichlmeier U, et al: Adjuvant treatment of clinical stage I seminoma: Is a single course of carboplatin sufficient? Urology 55:102-106, 2000
30. Steiner H, Holtl L, Wirtenberger W: Long-term experience with carboplatin monotherapy for clinical stage I seminoma: A retrospective single center study. Urology 60:324-328, 2002